Skip to content

Bedrest, Feeding Pattern, and Insulin Sensitivity

The Impact of Continuous Versus Intermittent Feeding on Changes in Insulin Sensitivity During Bed-rest

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02521025
Enrollment
20
Registered
2015-08-13
Start date
2015-10-31
Completion date
2016-04-30
Last updated
2016-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophy, Disuse, Insulin Resistance

Brief summary

In the present study, the investigators will assess the impact of two different feeding patterns (continuous vs intermittent) on insulin sensitivity and muscle mass following bedrest.

Detailed description

In the present study, the investigators will assess the impact of two different feeding patterns on insulin sensitivity and muscle mass following bedrest. Healthy, young males will be fed in a continuous (no breaks in food supply) or intermittent (in boluses throughout the day) manner.

Interventions

OTHERIntermittent feeding pattern

Intermittent feeding

OTHERContinuous feeding pattern

Continuous feeding

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18.5 and 35 * Recreationally active

Exclusion criteria

* Type 2 diabetes * Performing progressive resistance training in 6 months prior to study * Back/knee/leg problems * Hypertension * Use of certain anticoagulants * All co morbidities interacting with mobility and muscle metabolism of the lower limbs * Blood donation in past 3 months

Design outcomes

Primary

MeasureTime frame
Change in insulin sensitivity (measured as glucose infusion rate during hyperinsulinaemic-euglycaemic clamp)7 days bedrest

Secondary

MeasureTime frameDescription
Change in muscle mass (measured as upper leg muscle cross-sectional area with CT scan)7 days bedrestVia single-slice CT scan
Change in lean tissue (measured via DEXA scan)7 days bedrestVia DEXA

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026